Glenmark evaluating legal options over diabetes drugs setback
Drug firm Glenmark Pharmaceuticals today said it is evaluating legal options after the Delhi High Court restrained it from manufacturing and selling generic version of MSD's anti-diabetes medicines Januvia and Janumet.
Oct 08, 2015, 21:32 PM IST